International Journal of Cardiology
Volume 134, Issue 2 , Pages 180-188, 15 May 2009

The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography

  • Jun Tanigawa

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • First Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • ,
  • Peter Barlis

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
  • ,
  • Konstantinos Dimopoulos

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College, London, United Kingdom
  • ,
  • Miles Dalby

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
  • ,
  • Philip Moore

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
  • ,
  • Carlo Di Mario

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College, London, United Kingdom
    • Corresponding Author InformationCorresponding author. Royal Brompton Hospital, Sydney Street, SW3 6NP London, United Kingdom. Tel.: +44 20 7352 8121; fax: +44 20 7351 8473.

Received 11 February 2008; accepted 10 May 2008. published online 05 September 2008.

Abstract 

Background

Stent strut malapposition correlates with poor intimal coverage and this may increase the risk of late stent thrombosis. At present, there is limited data on whether stent strut thickness and stent design impact on acute apposition. We aimed to investigate the influence of stent strut thickness and design on acute stent strut apposition (SSA) immediately following drug-eluting stent (DES) implantation using optical coherence tomography (OCT), a technique with higher resolution and fewer artefacts than intravascular ultrasound.

Methods

Thirty-six DES in 23 patients (25 lesions) were studied by OCT. SSA was defined as embedded when a strut was buried in the intima for more than half its thickness, protruding when apposed to the intima but not embedded and malapposed when there was no intimal contact.

Results

Cypher Select stents were implanted in 52%, Taxus Liberte in 32%, Costar in 12% and Endeavour in 4%. A total of 6402 struts were evaluated. Despite stent optimisation using balloons with a final balloon/artery ratio of 1.26±0.19 at a maximum inflation pressure of 17.5±3.0 atm, only 57.1±20.7% of struts were embedded, whereas 33.8±18.4% were protruding and 9.1±7.4% were malapposed. Stent type was a strong predictor of malapposition on logistic multilevel analysis (OR 3.95, 95%CI: 1.27–12.23, p=0.017). At 12 months follow-up, there were no adverse clinical events.

Conclusion

Despite angiographic optimisation with high pressures and adequately sized balloons, malapposed stent struts are frequently found in complex coronary lesions and more often following the implantation of Cypher Select stents which have a thicker stent strut and closed cell design. With no adverse clinical events at 12 months follow-up, this likely represents a benign phenomenon at least as long as combined anti-platelet therapy is maintained.

Keywords: Angioplasty, Drug-eluting stents, Optical coherence tomography, Malapposition, Strut thickness

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-5273(08)00764-X

doi:10.1016/j.ijcard.2008.05.069

International Journal of Cardiology
Volume 134, Issue 2 , Pages 180-188, 15 May 2009